Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.

Esmé Kamphuis Laura Loman Henry L Han Geertruida L E Romeijn Klaziena Politiek Marie-Louise A Schuttelaar

Published in: Contact dermatitis (2023)

Upadacitinib can be an effective treatment for patients with AD and concomitant HE in daily practice. Future studies should focus on the effectiveness of upadacitinib on chronic HE, especially on the different etiological subtypes of HE, including HE in non-atopic individuals.

Keyphrases

atopic dermatitis
primary care
healthcare
randomized controlled trial
physical activity
mental health
quality improvement
replacement therapy
smoking cessation